Erik Sulman, MD, PhD, has been appointed chair of the Department of Radiation Oncology at Duke University School of Medicine effective August 1, 2025.

Lance Okeke, MD, was honored for outstanding contributions to the clinical research and translational science field.

As director of educational programs in the School of Medicine’s Office for Faculty, Jessica Schonberg, M.Ed., designs seminars that give faculty a chance to come together with their peers and discover new ways to make a meaningful impact at work.

Duke researchers hope to learn which forever chemicals are more toxic, and for whom — using tiny worms.

Watch Dean Klotman’s interview with Catherine Liao, Vice President of Duke Health Government Relations. In their conversation, they explore the team's strategic approach to fostering strong relationships with local, state, and national governmental entities, crucial for advancing Duke Health's missions.

A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.

Gayathri Devi, PhD, MS, professor of surgery and program leader of the Duke Consortium for Inflammatory Breast Cancer, was honored by the Association for Clinical and Translational Science for her work with Rare 2 Care, a global partnership to develop innovative diseases models, therapeutic strategies, and community-engaged research.

New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.

An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.

Researchers propose a "treatable fetal findings list" that identifies genetic conditions that can be detected with prenatal testing and treated in utero or in the first week of life.